Replies to post #324118 on Anavex Life Sciences Corp (AVXL)

[boi568]

Your favorite $10/day price for a Rett prescription would certainly be worth at least $3 per share to stockholders.

[Bourbon_on_my_cornflakes]

A majority of patients, 60%, stopped using treatments as prescribed when out-of-pockets costs exceeded $500.

Another reason that I believe that the price per month for Blarcamesine should be about $300 per month.

You could do $450 ($15 day) as the financial aid programs in the article would lower cost for poor patients.

Also remember insurance will pay some of the costs...the article mentions out of pocket costs which are after insurance contribution.